Identify and gather appropriate documents and data for review
2
Initial review of the Quality Assurance Program Plan (QAPP)
3
Evaluate compliance with regulatory and Organizational Policies
4
Review facility attributes such as location, size, equipment etc
5
Review the preclinical study protocols
6
Inspect study data, raw data, documentation, and test article control
7
Verify the handling of test and control articles
8
Confirm adequate training for personnel involved in the studies
9
Review the final reports of the completed studies
10
Ensure the Standard Operating Procedures (SOPs) are followed
11
Conduct interviews with staff and management
12
Identifying any instances of non-compliance
13
Approval: QA Manager to review initial findings and issues
14
Prepare preliminary audit findings report
15
Hold meeting with management to discuss findings
16
Follow-up actions to correct any non-compliance found
17
Prepare the final audit report
18
Approval: Senior Management to review final audit report
19
Release the final audit report
20
Schedule next audit date
Identify and gather appropriate documents and data for review
This task involves identifying and gathering all the necessary documents and data that will be reviewed during the FDA GLP audit. The goal is to ensure that all relevant information is available for the audit process. This may include reports, study protocols, records, and any other documentation related to the preclinical studies. The task also involves organizing the collected documents and data in a structured manner for easy access and reference during the audit.
Initial review of the Quality Assurance Program Plan (QAPP)
Before starting the audit, it is important to conduct an initial review of the Quality Assurance Program Plan (QAPP). The QAPP outlines the policies, procedures, and standards that ensure compliance with FDA GLP regulations. During this task, review the QAPP to gain an understanding of the organization's quality control measures, audit procedures, and overall compliance system. Pay special attention to any areas that require improvement or adjustment.
1
Training programs
2
Documentation procedures
3
Audit frequency
4
Equipment calibration
5
Data management
Evaluate compliance with regulatory and Organizational Policies
This task focuses on evaluating the organization's compliance with regulatory and organizational policies related to FDA GLP. Review the policies and procedures in place to ensure that they align with regulatory requirements. Look for any gaps or inconsistencies that may need to be addressed. Assess the effectiveness of the policies in promoting compliance and maintaining the integrity of the preclinical studies.
1
Full compliance
2
Partial compliance
3
Non-compliance
Review facility attributes such as location, size, equipment etc
This task involves reviewing the attributes of the facility where the preclinical studies are conducted. Assess the location, size, layout, and overall suitability of the facility for conducting GLP-compliant studies. Evaluate the equipment and resources available, ensuring that they meet the necessary requirements. Take note of any deficiencies or areas that require improvement to ensure the integrity and reliability of the study results.
Review the preclinical study protocols
In this task, review the preclinical study protocols that have been conducted at the facility. Evaluate the design, methodology, and execution of the studies to ensure compliance with FDA GLP regulations. Check if the protocols are well-documented and clearly outline the objectives, procedures, and data analysis methods. Identify any areas of improvement or potential non-compliance with the regulations.
1
Study design
2
Protocol documentation
3
Data analysis methods
4
Adherence to timeline
5
Sample size determination
Inspect study data, raw data, documentation, and test article control
Inspecting study data, raw data, documentation, and test article control is a crucial part of the FDA GLP audit. Review the collected data and documentation related to the preclinical studies. Ensure that the data is complete, accurate, and well-documented. Verify the control measures in place for test article handling to prevent contamination or mix-ups. Look for any issues or discrepancies that may affect the validity and reliability of the study results.
1
Study data completeness
2
Raw data documentation
3
Test article control measures
4
Data accuracy
5
Data traceability
Verify the handling of test and control articles
During this task, verify the handling of test and control articles throughout the preclinical studies. Assess the storage conditions, proper labeling, and segregation of test and control articles. Check if the articles are handled in accordance with FDA GLP regulations to prevent cross-contamination or misidentification. Identify any deviations from the required procedures and recommend corrective actions if necessary.
1
Improper labeling
2
Inadequate segregation
3
Cross-contamination
4
Misidentification
Confirm adequate training for personnel involved in the studies
This task focuses on confirming the adequacy of training provided to the personnel involved in the preclinical studies. Review the training records and qualifications of the individuals conducting the studies. Assess if they have received appropriate training on GLP regulations, study methodologies, and data handling. Identify any gaps in training and recommend additional training if necessary.
1
Training records and qualifications
2
GLP regulations knowledge
3
Study methodologies
4
Data handling techniques
5
Documentation practices
Review the final reports of the completed studies
This task involves reviewing the final reports of the completed preclinical studies. Assess the structure, content, and overall quality of the reports. Verify if the reports contain all the necessary information required by FDA GLP regulations. Check if the reports accurately summarize the study findings and provide appropriate conclusions. Identify any deficiencies or areas for improvement in the report generation process.
1
High quality
2
Moderate quality
3
Low quality
Ensure the Standard Operating Procedures (SOPs) are followed
In this task, ensure that the Standard Operating Procedures (SOPs) related to the preclinical studies are followed consistently. Review the SOPs to verify if they are up-to-date, well-documented, and aligned with FDA GLP regulations. Check if the personnel involved in the studies adhere to the prescribed procedures and record any deviations from the SOPs. Identify any gaps in the SOPs and recommend updates or modifications if necessary.
1
SOP documentation
2
Adherence to SOPs
3
Recorded deviations
4
SOP updates or modifications required
Conduct interviews with staff and management
Conducting interviews with staff and management provides additional insights and perspectives on the preclinical studies and the organization's compliance with FDA GLP regulations. During the interviews, ask relevant questions to understand their roles, responsibilities, and knowledge of the GLP requirements. Identify any potential gaps in understanding or implementation of the regulations and recommend necessary actions to address them.
1
Roles and responsibilities
2
Knowledge of GLP requirements
3
Implementation of GLP regulations
4
Identification of potential gaps
5
Recommended actions
Identifying any instances of non-compliance
During this task, identify any instances of non-compliance with FDA GLP regulations or organizational policies. Review all the collected information, observations, and findings from the audit process. Identify any inconsistencies, deviations, or violations that may compromise the integrity and reliability of the preclinical studies. Document the instances of non-compliance and provide recommendations for corrective actions.
1
Instances of non-compliance
2
Root causes
3
Impact on study integrity
4
Recommended corrective actions
5
Responsibility for corrective actions
Approval: QA Manager to review initial findings and issues
Will be submitted for approval:
Inspect study data, raw data, documentation, and test article control
Will be submitted
Prepare preliminary audit findings report
This task involves preparing a preliminary audit findings report based on the observations and identified instances of non-compliance. Summarize the key findings, including any areas of strength and areas requiring improvement. Provide a detailed analysis of the instances of non-compliance, their root causes, and recommendations for corrective actions. The preliminary audit findings report serves as a basis for further discussions with the management.
Hold meeting with management to discuss findings
In this task, hold a meeting with the management to discuss the preliminary audit findings and recommendations. Present the key findings, instances of non-compliance, and their impact on the preclinical studies. Engage in a constructive discussion to clarify any issues, address concerns, and provide further insights. Seek management's commitment to take appropriate actions to rectify the identified non-compliance and improve the organization's GLP compliance.
Follow-up actions to correct any non-compliance found
This task involves following up on the actions necessary to address the instances of non-compliance identified during the audit. Collaborate with the responsible individuals or teams to implement the recommended corrective actions. Ensure that the actions are effectively communicated, assigned to the relevant personnel, and documented for tracking and review. Monitor the progress of the corrective actions and provide support as needed.
1
Communication of corrective actions
2
Assignment of responsibilities
3
Documentation of actions
4
Progress monitoring
5
Support provided
Prepare the final audit report
This task involves preparing the final audit report based on the comprehensive assessment and all the collected information. Summarize the key findings, instances of non-compliance, and the implemented corrective actions. Provide a detailed analysis of the organizational strengths, improvements, and recommendations for sustained compliance. The final audit report serves as a conclusive document highlighting the audit outcomes and the organization's commitment to GLP compliance.
Approval: Senior Management to review final audit report
Will be submitted for approval:
Prepare preliminary audit findings report
Will be submitted
Release the final audit report
In this task, release the final audit report to the appropriate stakeholders, including the management, quality assurance team, and relevant personnel involved in the preclinical studies. Ensure that the report is comprehensive, well-structured, and clearly communicates the audit outcomes and recommendations. Consider any confidential or sensitive information that may require appropriate handling or redaction before releasing the report.
1
Review final audit report
2
Ensure confidentiality measures
3
Identify report recipients
4
Coordinate release
Schedule next audit date
This task involves scheduling the next audit date for the FDA GLP audit. Consider the frequency and requirements of the regulatory audits and the organization's internal audit program. Coordinate with the relevant stakeholders to identify a suitable timeframe for the next audit. Ensure that all necessary preparations and improvements are made before the scheduled audit date.
